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Abstract
Background: To investigate the efficacy and safety of the retention ring-assisted continuous application of 0.1%
riboflavin in pulsed-light accelerated corneal collagen cross-linking on the progression of keratoconus.
Methods: The medical records of 20 eyes of 18 patients with progressive keratoconus who received collagen cross-
linking at Seoul National University Hospital were retrospectively reviewed. Isotonic 0.1% riboflavin was continuously
applied for 10 min using an 8.0-mm retention ring before the irradiation and accelerated cross-linking was applied
with 30-mW pulsed-ultraviolet light at a wavelength 365 nm for eight minutes (1 s on/1 s off; 30mW/cm2, cumulative
dose of 7 .2J/cm2) without further intermittent application of riboflavin. Visual acuity, refractive error, topographic index,
corneal thickness, and endothelial cell density were evaluated before the operation and at 1, 3, 6, and 12months.
Results: The best corrected visual acuity in logMAR improved from preoperative 0.43 to 0.17 in 12months (p = 0.050).
Maximum keratometry decreased from 51.8 D to 50.4 D at 6 months (p = 0.015) and 50.1 D at 12months (p = 0.0003).
Astigmatism decreased from preoperative 5.5 D to 4.1 D at 12months (p < 0.0001). Thinnest corneal thickness decreased
at three and 6 months but recovered in 12months (p > 0.05). Endothelial cell density decreased at postoperative 1 month
(p = 0.02) but gradually recovered in 12months (p > 0.05).
Conclusions: Retention ring-assisted continuous application of riboflavin for 10 minutes in pulsed-light accelerated cross-
linking is a comparably safe and effective treatment for halting the progression of keratoconus in 12months when
compared to outcomes of the standard Dresden protocol shown in previous reports.
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Background
Keratoconus is an ectatic corneal disorder characterized
by progressive thinning and protrusion, accompanied by
irregular astigmatism and myopic progression, thereby de-
teriorating visual function. The conventional standardized
treatment is keratoplasty in advanced keratoconus [1].
Corneal collagen cross-linking has recently been investi-
gated to intervene in progression of moderate keratoco-
nus. In corneal cross-linking (CXL), riboflavin (vitamin
B2) acts as a photosensitizer. When it is combined with
ultraviolet A (UV-A) of 365-nm wavelength, oxygen radi-
cals are produced via photochemical reaction. Oxygen
radicals can introduce interfibrillar and intrafibrillar cova-
lent bonds among collagen fibrils [2, 3]. Such chemical
bonds can increase the corneal rigidity and its resistance
to enzymatic degradation of keratoconic cornea [4],
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thereby restoring the stability of the cornea and halting
the progression of keratoconus.
In the standard Dresden protocol, cornea is deepithelia-
lized using alcohol 20% solution and soaked in isotonic
0.1% riboflavin with 20.0% dextran solution for 30min. The
cornea is then irradiated with UV-A of 3mW/cm2 for 30
min (total energy 5 .4mJ/cm2). Riboflavin is intermittently
applied before and during the irradiation [5]. This protocol
can effectively stabilize the cornea of progressive keratoco-
nus in 10 years [6]. However, it is considered time-consum-
ing by some clinicians.
An accelerated cross-linking protocol was then intro-
duced to shorten the procedure. It applies UV-A of greater
intensity for a shorter irradiation time based on the Bun-
sen-Roscoe law of reciprocity [7]. According to the theory,
total energy delivered to the cornea remains identical. Its
biological effect is proportional to the energy delivered.
Surgical procedure of accelerated protocol is basically the
same as the standard Dresden protocol except two aspects;
the intensity (from 9 to 30mW/cm2) and irradiation time
of UV-A (from 3 to 15min) [8–16]. Many studies have re-
ported that clinical results of the accelerated protocol are
comparable to those of the standard Dresden protocol.
However, combination of intensity and irradiation time is
diverse. It has not been standardized yet. Furthermore, re-
cent meta-analyses have shown that the standard Dresden
protocol has better treatment efficacy in depth of demarca-
tion line and change of keratometric values than the accel-
erated protocol [15, 16].
A study on photochemical kinetics of cross-linking has
shown that continuous UV-A irradiation can induce rapid
depletion of oxygen in riboflavin applied corneal tissue
and that turning the UV off can replenish oxygen level
[17]. Photodynamic reaction between riboflavin molecules
and UV-A can induce release of reactive oxygen species
(ROS) and introduces cross-linking in collagen fibers. Ac-
cording to the kinetics model, pulsing the UV-A irradi-
ation theoretically can restart the photodynamic reaction
and maintain ROS concentration in the cornea [17]. Based
on these findings, pulsed-light accelerated cross-linking
had been adopted to enhance treatment efficacy. It has
been reported to be as effective as the standard Dresden
protocol [18–20].
So far, there is no standardized method for riboflavin
application in the accelerated protocol. The protocol
provided by the manufacturer (Avedro. Inc., Waltham,
MA, USA) recommends intermittent application of iso-
tonic riboflavin every 2 minutes for a total of 10 minutes.
Recent studies have reported different clinical efficacies
with various application time (from 10 to 30min) and in-
tervals (2 to 5 minutes) [9–12, 19]. Shorter application
time (every 2 minutes for 10min) seems to have lower ef-
ficacy, even in pulsed-light accelerated protocol, than the
standard protocol [12]. In addition, our group has recently
demonstrated possible damage to the limbal stem-cell area
by exposure to riboflavin during cross-linking [21]. Thus,
it is necessary to protect the corneal limbal area and pre-
vent it from exposure to riboflavin and UV.
To enhance the efficacy of cross-linking in progressive
keratoconus and add limbal protection, our group adopted
pulsed-light cross-linking protocol with two modifications.
First, we introduced a retention ring for the application of
riboflavin in order to apply riboflavin continuously (10min)
for better penetration into the cornea while enhancing the
efficacy and reducing exposure of limbal area to riboflavin.
Second, we applied a trephined silicone hydrogel bandage
contact lens on limbal area during irradiation of UV-A to
protect it from toxic effect of UV [21]. UV-A was irradiated
in a pulsatile mode (1 s on and off) for a total of 8min with
total energy of 7 .2J/cm2 as described in a previous report
[18]. We hypothesized that this novel method of retention
ring-assisted continuous application of 0.1% riboflavin for
10 minutes in pulsed-light accelerated cross-linking might
have better or comparable efficacy and safety profile for
halting the progression of keratoconus than other pulsed
modes, accelerated cross-linking protocol, or standard
Dresden protocol described in previous reports.
Methods
Patients
This study was approved by the Institutional Review
Board of Seoul National University College of Medicine
(IRB No. 1807–139-961, Seoul, South Korea) and ad-
hered to the Declaration of Helsinki. It included 20 eyes
of 18 patients with progressive keratoconus who re-
ceived CXL at a single institution (Seoul National Uni-
versity Hospital) by a single surgeon (M.K. Kim). The
medical records of the 18 patients (14 male and 4 female
patients) were retrospectively reviewed. The mean age
was 28.0 ± 7.3 (range 17–43) years, and all patients were
treated with the same protocol.
Inclusion and exclusion criteria
The patients who were diagnosed with progressive kerato-
conus and underwent accelerated CXL were included in
the study. Progression was confirmed by an increase of
maximum keratometry (Kmax) of more than 1.5 diopters
(D) / year in serial topography. Those with preoperative
Kmax greater than 60 D or central corneal thickness
(CCT) less than 400 μm or thinnest corneal thickness
(TCT) less than 390 μm were excluded. Patients combined
with other ocular surface diseases were also excluded.
Clinical evaluation
Preoperative and postoperative examinations included
best-corrected visual acuities (BCVA) as a logarithm of
the minimum angle of resolution (logMAR), refractive
errors by Auto Kerato-Refractometer (KR-8900, Topcon,
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Tokyo, Japan), keratometric values including maximum
(Kmax), minimum (Kmin), average (Kavg), and 3 mm and
5mm irregular index by topography (ORBSCAN IIz,
Technolas Perfect Vision GmbH, München, Germany).
Corneal thickness (CT) was measured by anterior seg-
ment optical coherence tomography (AS-OCT, Visante
OCT; Carl Zeiss Meditec, Dublin, CA). Noncontact
specular microscopy (SP-8800, Konan, Hyogo, Japan)
was used to measure endothelial cell density. Preopera-
tive measurements were compared with the postopera-
tive measurements at 1, 3, 6, 12 months.
Surgical procedure
Eyes were anesthetized with topical 1% proparacaine
(Alcaine; Alcon, Fort Worth, TX) and the central 9.0-mm
corneal epithelium was peeled off using a crescent knife
(Beaver; Beaver-Visitec, Waltham, MA). Intraoperative
pachymetry (Pocket II; Quantel Medical, Bozeman, MT)
was performed to make sure that the corneal thickness was
greater than 325 μm. A retention ring 8.0mm in diameter
(Frimen, Inc., Jiangsu, China) was applied on the epi-off
corneal surface, and 0.1% isotonic riboflavin (Vibex Rapid,
Avedro, Inc., Waltham, MA, USA) with dextran-free hy-
droxypropyl methylcellulose (HPMC; VibeX Rapid, Avedro,
Waltham, MA) was continuously applied for 10 minutes
within the retention ring (Additional file 1: Figure S1 A).
Then, a trephined (inner diameter, 8.5mm) silicone hydro-
gel bandage contact lens (ACUVUE OASYS; Johnson &
Johnson Vision Care, Jacksonville, FL) was applied to cover
the limbus from UV irradiation (Additional file 1:Figure S1
B and C). Pulsing (1 s. on/off) 30mW/cm2 intensity of
365-nm wavelength UV-A (Avedro, Waltham, MA) was
irradiated for 8 minutes, resulting in a cumulative dose of
7 .2J/cm2. During the irradiation, riboflavin was not applied.
After irradiation, the corneal surface was irrigated with a
balanced salt solution, and the silicone hydrogel bandage
contact lens was applied. The bandage contact lens was
maintained for 7 days with topical 0.5% moxifloxacin and
1% prednisolone four times a day.
Statistical analysis
Statistical analysis was performed using Prism 5 software
(Graphpad Software, Inc., San Diego, CA). The two-tailed
Student’s t test was used to compare each of the baseline
parameters with the following measurement. The data are
presented with mean value ± mean standard deviation
(SD), and statistical significance was verified if p < 0.05.
Results
This study analyzed a total of 20 eyes of 18 patients over
a mean postoperative follow-up of 12.7 ± 1.5 months.
The demographics and baseline characteristics of the
study group are shown in Table 1. The mean age at the
time of the procedure was 28.0 ± 7.3 years. Mean depth
of the demarcation line was 281.0 ± 39.9 μm (minimum
210 μm to maximum 380.0 μm) (Additional file 2: Figure
S2, Table 1). The penetration depth (demarcation line)
in our study is comparable to or deeper than that in
other studies on standard Dresden protocol or acceler-
ated cross-linking protocols (Table 2).
The best corrected visual acuity gradually improved from
preoperative 0.43 ± 0.43 logMAR to 0.17 ± 0.16 logMAR at
12months with a marginal significance (p = 0.050) (Fig. 1a)
and uncorrected visual acuity also improved, from 0.81 ±
0.38 logMAR to 0.49 ± 0.50 logMAR at 12months,
although it was not statistically significant (p = 0.635) (Fig.
1b). Refractive errors decreased from − 7.40 ± 2.80 D to −
6.25 ± 3.11 D in spherical (p = 0.245), − 4.81 ± 1.36 D to −
4.00 ± 2.07 D in cylinder (p = 0.003) and − 9.81 ± 2.93 D to
− 8.25 ± 2.98 D in spherical equivalent (p = 0.075) after 12
months, and remained stable thereafter respectively) (Fig.
1c and d). Cylindrical reduction was a statistically signifi-
cant with this modified protocol.
Keratometric values were delineated as Kmax (maximum),
Kmin (minimum), and Kavg (average). Kmax (Fig. 2a) signifi-
cantly decreased from 51.85 ± 4.11 D to 50.36 ± 3.55 D at 6
months (p = 0.015) and 50.11 ± 3.62 D at 12months (p =
0.0003). Kmin (Fig. 2b) decreased, from 46.40 ± 2.19 D to
45.99 ± 2.27 D at 12months (p = 0.113) although it was in-
significant. Kavg (Fig. 2c) also significanly decreased from
49.12 ± 2.95 D to 48.55 ± 2.79 D at 6 months (p = 0.045)
and 48.05 ± 2.69 D (p = 0.0028) at 12months. Topographic
astigmatism was significantly reduced from preoperative
5.45 ± 2.90 D to 4.23 ± 2.27 D at 6 months (p = 0.006) and
4.10 ± 2.75 D at 12months (p < 0.0001) (Fig. 2d). Irregular
index at 3mm and 5mm decreased from preoperative 6.27
± 2.16 D to 5.06 ± 1.53 D (p = 0.006) and 6.11 ± 1.82 D to
5.36 ± 1.38 D (p = 0.017), and the reductions were statisti-
cally significant at 12months. (Fig. 2e and f).
Central corneal thickness showed a significant decrease,
from 495.9 ± 36.1 μm to 484.5 ± 41.4 μm in 12months (p
= 0.020) (Fig. 3a). Thinnest corneal thickness was tempor-
arily decreased at 6 months (p = 0.0025), but eventually re-
covered to 460.5 ± 38.3 μm in 12months, resulting in no
statistical difference compared with the preoperative level
(p > 0.05, pre-operation vs 12 mo.) (Fig. 3b).
Endothelial cell density significantly decreased, from
preoperative 2693 ± 223 cells/mm2 to 2434 ± 460 cells/
mm2 at 1 month (p = 0.018), but gradually recovered
back in 12 months (2621 ± 471 cells/mm2) without any
significant change compared with preoperative level or
3 months (p = 0.325, preop vs 12 mo., p = 0.08, 3 mo. vs
12 mo.) (Fig. 3c).
There was a single case of delayed wound healing,
which spontaneously resolved in 14 days with conserva-
tive treatments using preservative artificial tear; other-
wise, there were no serious complications related to the
procedure.
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Discussion
In this study, we report that retention ring-assisted con-
tinuous application of riboflavin for 10 minutes in
pulsed-light accelerated cross-linking is as effective as
standard Dresden protocol or more effective than other
pulsed-light accelerated cross-linking protocols for halt-
ing the progression of keratoconus in 12 months. With
regard to safety, endothelial cell density changes in 12
months of this protocol are comparable to outcomes de-
scribed in previous reports (Table 2).
To date, there is no consensus on a standardized proto-
col for accelerated cross-linking comparable to the stand-
ard Dresden protocol, which has been documented to be
effective in treating progressive keratoconus by improving
corrected distance visual acuity, decreasing keratometric
values, and preserving endothelial cells in a ten-year
follow-up study [6]. To improve efficacy, a pulsed-light
accelerated protocol was first introduced, showing better
functional outcomes in 1 year by optimizing intraoperative
oxygen availability than the standard Dresden protocol
[18]. It also showed effectiveness in a two-year follow-up
[20]. Nevertheless, recent meta-analysis studies generally
indicate that the standard Dresden protocol has better effi-
cacy than for the accelerated protocol with a deeper
demarcation line [15, 16]. However, protocol modification
is still required to improve outcomes of the accelerated
protocol. We hypothesized that continuous application of
riboflavin using a retention ring might induce deeper
penetration of riboflavin and increase the availability of
riboflavin in corneal tissue, thus enhancing the efficacy of
treatment.
To shorten the procedure time without reducing its ef-
ficacy, we aimed to modify the application method of
riboflavin by continuously using a retention ring before
irradiation. The overall clinical effect of our modified
protocol on visual acuity, topographic parameters and
demarcation line depth was comparable to that of the
standard Dresden protocol or better than other studies
with accelerated cross-linking (Table 2). The depth of
demarcation line in this study was the greatest (281 μm)
among pulsed-light accelerated protocols reported (202
~ 280 μm). It was comparable with other continuous ac-
celerated protocols (184 ~ 317 μm) or the standard Dres-
den protocol (280 ~ 442 μm). The mean visual
improvement was − 0.25 logMAR in our study, which
was better than the outcome in the accelerated protocol
(− 0.01 ~ − 0.14 logMAR) and the standard Dresden
protocol (− 0.05 ~ − 0.13 logMAR). The mean reduction
of maximum keratometry was − 1.54 D in our study. It
was greater that of other accelerated protocols (− 0.3 D
~ − 1.31 D) and comparable to that of the standard
Dresden protocol (− 0.76 D ~ − 1.80 D) (Table 2). There-
fore, our modified ten-minute continuous application of
riboflavin in a pulsed-light accelerated protocol has bet-
ter efficacy than other accelerated protocols. It is as effi-
cient as the standard Dresden protocol in halting the
progression of keratoconus.
Because of the possibility of limbal stem cell damage
during riboflavin application and UV irradiation [21],
modification of the previous protocol as essential. In our
in vivo experiments [21], a significantly greater decrease
of p63+ stem cells was observed when riboflavin was
dropped on the whole corneal surface in accelerated
cross-linking when compared to the protocol using the
retention ring to confine riboflavin to only the central
cornea. We believe that protecting the limbal stem cells
by minimizing their exposure to riboflavin and UV is
important, given their crucial role in regeneration of
cells. Further experimental studies on concentration-
and duration-dependent toxicity of riboflavin are needed
to elucidate cellular injury and standardize the protocol.
Table 1 Baseline characteristics of the patients who underwent
pulsed accelerated cross-linking in this study
Demographic factors
Eyes 20 eyes of 18 patients
Sex 14 male (77.7%), 4 female (22.3%)
Age (year) 28.0 ± 7.3
Systemic disease / Atopy 0 (0%) / 2 (11%)
FU (month) 61.3 ± 53.6
POD (month) 12.8 ± 1.0
BCVA (logMAR) 0.43 ± 0.43
UCVA (logMAR) 0.81 ± 0.38
Refractive error
Spherical (diopter) −7.40 ± 2.80
Cylinder (diopter) −4.81 ± 1.36
SE (diopter) −9.81 ± 2.93
Topography
Kmax (diopter) 52.20 ± 4.32
Kmin (diopter) 46.50 ± 2.18
Kavg (diopter) 49.35 ± 3.06
Astigmatism 5.71 ± 3.07
IR, 3 mm 6.38 ± 2.17
IR, 5 mm 6.23 ± 1.86
AS-OCT
CCT (μm) 492.1 ± 39.1
TCT (μm) 466.6 ± 37.1
ECD (cells/ mm2) 2731 ± 279.5
Depth of demarcation line
after 1mo of cross-linking (μm)
281.0 ± 39.9
Values are presented as mean ± SD, FU, follow up; POD, postoperative date;
BCVA, best-corrected visual acuity; UCVA, uncorrected visual acuity; logMAR,
logarithm of minimum angle of resolution; SE, spherical equivalent; IR,
irregular astigmatism; CCT, central corneal thickness; TCT, thinnest corneal
thickness; AS-OCT, anterior segment optical coherence tomography; ECD,
endothelial cell density
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Fig. 1 Changes of best corrected visual acuity (BCVA, logMAR) (a), uncorrected visual acuity (UCVA, logMAR) (b) and spherical (c), cylindrical (d)
refractive errors (diopter) over time following modified pulsed-light accelerated cross-linking
Fig. 2 Corneal topographic changes (diopter) following modified pulsed-light accelerated cross-linking over time. Kmax (a), Kmin (b), Kavg (c),
astigmatism (d), and irregular astigmatism (IR) at 3 mm (e) and at 5 mm (f)
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In our study, endothelial cell density was significantly
reduced in postoperative 1 month compared to that
pre-operatively (p = 0.02). It is plausible that continuous
application of riboflavin may penetrate deeper microscop-
ically than the depth that the grossly visible demarcation
line indicates. This may subsequently lead to effect of UV
on endothelial cells immediately post-operation. The loss
of endothelial cells (− 9.61%) was not clinically significant
to induce corneal edema. In addition, endothelial cell
density gradually recovered and maintained up to postop-
erative 12months. The overall reduction was not statisti-
cally significant (− 2.67%, preop vs 12months). It was a
comparable change (− 91 cells/cm2) when we compared it
with previous data (− 54 ~ − 247 cells/cm2, Table 2). Most
of previous studies including the accelerated protocol
demonstrated no clinically significant reduction of ECD
after 12months (Table 2) [15, 16]. Meanwhile, one study
has shown a significant reduction of ECD up to 12months
after accelerated cross-linking in keratoconus [22]. An an-
ecdotal report has presented corneal edema after
cross-linking [23]. Therefore, endothelial damage should
be carefully monitored when we modify these procedures.
Further study is needed to explore the most appropriate
continuous application time of riboflavin with the same
efficacy and enhanced safety.
In this study, two patients had corneal cross-linking bi-
laterally. These procedures were performed sequentially
without simultaneous application. It was not an intentional
intra-patient control because this was a retrospective study.
In fact, we conducted cross-linking in one eye in each pa-
tient, and cross-linking improved visual acuity significantly.
Consequently, these patients were very satisfied with the
surgical outcome and wanted to undergo cross-linking for
the other eye. Subsequently, they underwent cross-linking
for the contralateral eyes.
This study was limited because it did not include a dir-
ect control group with Dresden protocol. In addition,
the sample size was small. Instead, we compared the effi-
cacy and safety of our modified protocol with those of
the Dresden protocol described in previous reports
(Table 2). They showed comparable outcomes. This is
the first report on a novel method with clinically signifi-
cant one-year follow-up outcomes.
Conclusion
Retention ring-assisted continuous application of ribofla-
vin for 10 minutes in pulsed-light accelerated cross-link-
ing is a comparably effective and safe treatment for
halting the progression of keratoconus in 12months when
compared to outcomes of the standard Dresden protocol
described in previous reports.
Additional files
Additional file 1: Supplementary Figure S1. Riboflavin is contained
inside a retention ring during the application for 10 minutes (A). A
trephined silicone hydrogel bandage contact lens is applied during UV
irradiation (B, C) (TIF 9431 kb)
Additional file 2: Supplementary Figure S2. Slit-lamp biomicroscopy
exam after a month of modified pulsed-light accelerated cross-linking
demonstrated a demarcation line (A, yellow arrow). Anterior segment op-
tical coherence tomography-assisted measurement of demarcation line
depth (B, yellow arrow) (TIF 6419 kb)
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AS-OCT: antesrior segment optical coherence tomography; BCVA: best
corrected visual acuity; CCT: central corneal thickness; CXL: cross-linking;
D: diopter; DDL: depth of demarcation line; ECD: endothelial cell density;
FU: follow up; IR: irregular astigmatism; Kavg: average keratometric value;
Kmax: maximal keratometric value; Kmin: minimal keratometric value;
LogMAR: logarithm of minimal angle of resolution; POD: postoperative date;
SD: standard deviation; SE: spherical equivalent; TCT: thinnest corneal
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